We asked three supplier companies with cleaning and finishing capabilities and a focus on AM to speak on successful techniques they see in use, and challenges that OEM customers are asking them to solve.
Continue to article
Extremities replacement device revenue reached nearly $2.8 billion in 2018, making it an attractive area for product introductions. We're highlighting six shoulder and ankle FDA clearances granted since the beginning of the year.
We've covered 20 OEM-related merger and acquisition announcements so far this year, and seven of them are related to the spine sector. Of those, three were announced in rapid succession this quarter. Here's our in-depth look.
FDA 510(k) clearance was received to market the TIGER SHARK C interbody device with BioBond and the BOOMERANG Anterior Cervical Plate, for use together or separately in cervical spinal fusion.
Click to read more